News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,722 Results
Type
Article (17496)
Company Profile (17)
Press Release (163207)
Multimedia
Podcasts (22)
Webinars (9)
Section
Business (52093)
Career Advice (382)
Deals (8652)
Drug Delivery (52)
Drug Development (30737)
Employer Resources (38)
FDA (4829)
Job Trends (4581)
News (94294)
Policy (8492)
Tag
Academia (1030)
Accelerated approval (7)
Adcomms (14)
Allergies (48)
Alliances (12668)
ALS (58)
Alzheimer's disease (1108)
Antibody-drug conjugate (ADC) (94)
Approvals (4802)
Artificial intelligence (163)
Autoimmune disease (29)
Automation (8)
Bankruptcy (61)
Best Places to Work (3706)
BIOSECURE Act (8)
Biosimilars (44)
Biotechnology (11)
Bladder cancer (69)
Brain cancer (20)
Breast cancer (271)
Cancer (1854)
Cardiovascular disease (140)
Career advice (335)
Career pathing (20)
CAR-T (110)
CDC (16)
Cell therapy (265)
Cervical cancer (21)
Clinical research (25764)
Collaboration (480)
Company closure (2)
Compensation (85)
Complete response letters (24)
COVID-19 (1401)
CRISPR (29)
C-suite (268)
Cystic fibrosis (48)
Data (1954)
Decentralized trials (1)
Denatured (5)
Depression (44)
Diabetes (166)
Diagnostics (3018)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (73)
Drug pricing (78)
Drug shortages (15)
Duchenne muscular dystrophy (87)
Earnings (21532)
Editorial (32)
Employer branding (5)
Employer resources (40)
Events (20933)
Executive appointments (411)
FDA (5774)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (477)
Gene editing (77)
Generative AI (15)
Gene therapy (240)
GLP-1 (422)
Government (1582)
Grass and pollen (2)
Guidances (141)
Healthcare (5298)
HIV (15)
Huntington's disease (19)
IgA nephropathy (26)
Immunology and inflammation (123)
Immuno-oncology (11)
Indications (23)
Infectious disease (1492)
Inflammatory bowel disease (52)
Inflation Reduction Act (5)
Influenza (30)
Intellectual property (65)
Interviews (82)
IPO (4242)
IRA (23)
Job creations (1044)
Job search strategy (260)
Kidney cancer (8)
Labor market (26)
Layoffs (266)
Leadership (13)
Legal (1447)
Liver cancer (34)
Longevity (3)
Lung cancer (276)
Lymphoma (140)
Machine learning (16)
Management (14)
Manufacturing (212)
MASH (64)
Medical device (3286)
Medtech (3294)
Mergers & acquisitions (4665)
Metabolic disorders (465)
Multiple sclerosis (71)
NASH (12)
Neurodegenerative disease (130)
Neuropsychiatric disorders (30)
Neuroscience (1565)
NextGen: Class of 2025 (1611)
Non-profit (1384)
Now hiring (4)
Obesity (248)
Opinion (148)
Ovarian cancer (57)
Pain (51)
Pancreatic cancer (93)
Parkinson's disease (118)
Partnered (11)
Patents (113)
Patient recruitment (119)
Peanut (19)
People (16340)
Pharmaceutical (3)
Pharmacy benefit managers (10)
Phase I (8109)
Phase II (11517)
Phase III (9086)
Pipeline (1271)
Policy (105)
Postmarket research (711)
Preclinical (2717)
Press Release (28)
Prostate cancer (90)
Psychedelics (16)
Radiopharmaceuticals (109)
Rare diseases (287)
Real estate (1419)
Recruiting (14)
Regulatory (6774)
Reports (12)
Research institute (991)
Resumes & cover letters (44)
Rett syndrome (8)
RNA editing (9)
RSV (34)
Schizophrenia (58)
Series A (90)
Series B (63)
Service/supplier (1)
Sickle cell disease (26)
Special edition (8)
Spinal muscular atrophy (89)
Sponsored (13)
Startups (1485)
Stomach cancer (7)
Supply chain (20)
Tariffs (56)
The Weekly (17)
Vaccines (427)
Venture capital (42)
Weight loss (180)
Women's health (18)
Worklife (6)
Date
Today (53)
Last 7 days (206)
Last 30 days (897)
Last 365 days (11303)
2025 (8775)
2024 (11904)
2023 (13197)
2022 (16113)
2021 (16894)
2020 (15866)
2019 (12181)
2018 (9472)
2017 (9517)
2016 (8515)
2015 (9587)
2014 (6452)
2013 (4774)
2012 (5213)
2011 (5505)
2010 (4806)
Location
Africa (215)
Alabama (19)
Alaska (1)
Arizona (50)
Arkansas (3)
Asia (11324)
Australia (2268)
California (3121)
Canada (810)
China (336)
Colorado (102)
Connecticut (123)
Delaware (104)
Europe (27775)
Florida (405)
Georgia (72)
Idaho (7)
Illinois (212)
India (19)
Indiana (139)
Iowa (5)
Japan (125)
Kansas (42)
Kentucky (4)
Louisiana (3)
Maine (14)
Maryland (333)
Massachusetts (2325)
Michigan (66)
Minnesota (98)
Mississippi (1)
Missouri (29)
Montana (5)
Nebraska (8)
Nevada (33)
New Hampshire (36)
New Jersey (919)
New Mexico (12)
New York (909)
North Carolina (307)
Northern California (1502)
Ohio (68)
Oklahoma (7)
Oregon (12)
Pennsylvania (572)
Puerto Rico (7)
Rhode Island (9)
South America (241)
South Carolina (4)
Southern California (1184)
Tennessee (22)
Texas (593)
United States (10895)
Utah (95)
Virginia (56)
Washington D.C. (24)
Washington State (232)
West Virginia (1)
Wisconsin (39)
180,722 Results for "earli".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioMark Secures Key Patents in Asia’s Largest Markets for Early Lung Cancer Liquid Biopsy
Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.
September 29, 2025
·
3 min read
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Cancer
Moderna Claims Early Victory for Cancer Antigen in Melanoma
Moderna’s mRNA-4359, when used with Keytruda, achieves a 24% overall objective response rate in patients with melanoma, with efficacy increasing to 67% in those positive for PD-L1.
October 13, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
To Compete in Obesity, Late Entrants Invest Early in Manufacturing
Small and large drugmakers alike have made big, proactive moves to secure the production capacity that will be vital to serving the weight loss market.
September 23, 2025
·
5 min read
·
Nick Paul Taylor
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led firms to make tough pipeline decisions early in the development process. The result may be costly for all of us.
May 21, 2025
·
5 min read
·
Michael N. Abrams
Press Releases
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
October 3, 2025
·
5 min read
Artificial intelligence
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
Nabla and Takeda first joined hands in 2022, to push “the boundaries of next-generation biologics discovery,” according to the startup’s CEO Surge Biswas.
October 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
October 1, 2025
·
7 min read
Press Releases
IQVIA Announces CFO Transition in Early 2026
September 3, 2025
·
4 min read
Press Releases
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability to Distinguish Early Lung Cancer from Other Non-Cancerous Lung Diseases
May 12, 2025
·
4 min read
1 of 18,073
Next
